Savvy Psychopharmacology

How differences among generics might affect your patient’s response

Author and Disclosure Information

 

References

If you have a question about generic substitution, consult the FDA’s Approved drug products with therapeutic equivalence evaluations4—also known as the “Orange Book,” which is available online (see Related Resources). This resource provides guidance about which drugs are interchangeable. The Orange Book is the “gold standard” on approved drug products and their interchangeability.

The Table lists certain psychiatric medications that may have issues with generic substitutions. Most pharmacies stock and dispense only generic drugs that the FDA considers bioequivalent to the brand-name product.

Allergic reactions may occur because of different inert ingredients within each generic or brand-name drug. Generic drug manufacturers are not required to use the same inactive or “filler” ingredients. Some patients may be allergic to 1 version and may require a specific brand or generic version to overcome this potential allergy.3

Although most generic substitutions occur without incident, consider BE differences among products and your patient’s medical condition before initiating a switch. When switching between generics, carefully monitor your patient as you would when switching from the brand-name product to a generic. If new treatment-related issues arise or lack of efficacy occurs, ask your patient if the pharmacy switched to a new generic formulation.

Table

Bioequivalence among generic psychotropics: What to know before you switch

MedicationComments
Amitriptyline/perphenazineGeneric formulations may not be interchangeable*
AnticonvulsantsBecause these medications have a narrow therapeutic index when used for seizure disorders, patients are recommended to not switch formulations. When used for psychiatric disorders, the margin of safety is unknown and switching may be appropriate
ChlorpromazineGeneric formulations are not bioequivalent
ClozapineGeneric formulations may not be bioequivalent at all dosages*
Dosage adjustments may be needed in patients who need to switch formulations during treatment
VenlafaxineSome formulations may not be interchangeable*
*Consult the FDA’s Approved drug products with therapeutic equivalence evaluations to determine if generics are interchangeable
Source: Reference 4

Related resources

Drug brand names

  • Amitriptyline/Perphenazine • Triavil
  • Chlorpromazine • Thorazine
  • Clozapine • Clozaril
  • Fluoxetine • Prozac
  • Venlafaxine • Effexor

Disclosure

Dr. Ellingrod is a member of an advisory board for Eli Lilly and Company.

Pages

Recommended Reading

Can Nostalgia Lead to Clinical Depression?
MDedge Psychiatry
Antidepressants and Nonadherence
MDedge Psychiatry
Stick With Positive Trial Results When Prescribing Antidepressants
MDedge Psychiatry
Relationship Seen Between Falls, Depression in Preschoolers
MDedge Psychiatry
Some Men Talk About Depression Differently : Older men should be encouraged to talk about changes in work, health, and family context.
MDedge Psychiatry
Persistence Critical in Severe Teen Depression
MDedge Psychiatry
Discontinuing an antidepressant?
MDedge Psychiatry
Osteoporosis in depression: Which patients are at risk?
MDedge Psychiatry
Sad Dad: Identify depression in new fathers
MDedge Psychiatry
SAD: Is seasonal affective disorder a bipolar variant?
MDedge Psychiatry